Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05062161 · ClinicalTrials.gov registry record · NA
Sleep Duration and Blood Pressure During Sleep
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT05062161: Completed NA study, sponsored by Columbia University.
NCT05062161 is a NA study that has completed, run by Columbia University. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05062161, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact that sleep duration has on blood pressure (BP) levels during sleep. The investigator will examine the effect of an 8-week sleep hygiene/extension intervention vs. control on sleep BP.
Primary Outcome
Mean of valid BP readings during the sleep period on 24-hour ambulatory blood pressure monitor will be calculated to obtain mean sleep systolic BP (mmHg) at baseline and 8 weeks.
Interventions
- BEHAVIORAL Sleep hygiene/extension intervention
- BEHAVIORAL Control care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT05062161 record still lists
NCT05062161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Sleep hygiene/extension intervention is the first listed.
NCT05062161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05062161 about?
NCT05062161 is a clinical study titled "Sleep Duration and Blood Pressure During Sleep". The purpose of this study is to examine the impact that sleep duration has on blood pressure (BP) levels during sleep. The investigator will examine the effect of an 8-week sleep hygiene/extension intervention vs. control on sleep BP.
What is the current status of trial NCT05062161?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-09-30. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05062161?
The interventions under investigation include: Sleep hygiene/extension intervention (BEHAVIORAL), Control care (BEHAVIORAL).
Who is sponsoring clinical trial NCT05062161?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05062161's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI